Finance Watch: Joe Jimenez Ventures Into Start-Up World Via Aditum
Also, Three New Biopharma IPOs Bring 2020 Total To 74 In US
Former Novartis CEO Jimenez co-founded Aditum with former NIBR president Mark Fishman; they raised $133m and are launching Tempero Bio. Also, Atea, Galecto and SQZ went public along with one more health care SPAC, Royalty Pharma upped its Vertex royalty revenues and Mirati’s FOPO raised $926.3m.
